Equities

AK Sigorta AS

AKGRT.E:IST

AK Sigorta AS

Actions
FinancialsNon-life Insurance
  • Price (TRY)5.77
  • Today's Change-0.04 / -0.69%
  • Shares traded11.14m
  • 1 Year change+0.35%
  • Beta1.1576
Data delayed at least 15 minutes, as of Nov 13 2024 15:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy0
Outperform1
Hold0
Sell0
Strong Sell0

Share price forecast

The 2 analysts offering 12 month price targets for AK Sigorta AS have a median target of 8.89, with a high estimate of 9.13 and a low estimate of 8.66. The median estimate represents a 54.07% increase from the last price of 5.77.
High58.2%9.13
Med54.1%8.89
Low50.1%8.66

Dividends

Dividend information is not available for AK Sigorta AS.
Div growth (TTM)--
More ▼

Earnings history & estimates in TRY

AK Sigorta AS reported annual 2023 earnings of 0.714 per share on Feb 08, 2024.
Average growth rate-19.60%
More ▼

Revenue history & estimates in TRY

Aksigorta A.S. had revenues for the full year 2023 of 9.55bn. This was 94.36% above the prior year's results.
Average growth rate+48.53%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.